Xeris Biopharma Holdings (XERS) Earnings Analysis
Xeris Biopharma Holdings (XERS) next reports earnings on 2026-08-06, consensus EPS 0.02 USD. Last quarter (2026-05-07) it beat with EPS 0.01 USD vs -0.00274 USD est (+465%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E 118.36.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does XERS next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.02 USD |
| Revenue estimate | 0.09B |
XERS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.01 USD | -0.00274 USD | +465% | Beat |
| 2026-03-02 | 0.06 USD | 0.03 USD | +100% | Beat |
| 2025-11-06 | 0.0035 USD | 0.01 USD | -65% | Miss |
| 2025-05-08 | -0.06 USD | -0.07 USD | +14.3% | Beat |
| 2025-03-06 | -0.03 USD | -0.08 USD | +62.5% | Beat |
| 2024-11-08 | -0.06 USD | -0.09 USD | +33.3% | Beat |
| 2024-08-08 | -0.1 USD | -0.11 USD | +9.1% | Beat |
Beat rate: 6/7 (86%) over reported quarters with consensus data.
XERS valuation and analyst view
| Trailing P/E | 118.36 |
|---|---|
| Trailing EPS | 0.07042 USD |
| Price / book | 109.83 |
| Dividend yield | 0.00% |
| Market cap | 1.46B |
| Analyst consensus | Buy (9 buy / 1 hold / 0 sell) |
| Avg price target | 13.5 USD |
Related research pages
Frequently asked questions
When is Xeris Biopharma Holdings (XERS)'s next earnings date?
Xeris Biopharma Holdings is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.02 USD and revenue estimate of 0.09B.
Did XERS beat earnings last quarter?
In its 2026-05-07 report, XERS posted EPS of 0.01 USD versus a -0.00274 USD estimate — a beat of 465%.
What is XERS's earnings track record?
Over the last 7 reported quarters with consensus data, XERS beat estimates 6 times (86%).
What is XERS's current P/E ratio and EPS?
XERS trades at a trailing P/E of 118.36 on trailing EPS of 0.07041856730727233 USD.
What do analysts rate XERS?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 13.5 USD.